Focal palmoplantar and gingival keratoderma
disease diseaseOn this page
Also known as focal palmoplantar and gingival hyperkeratosisfocal palmoplantar and oral mucosa hyperkeratosiskeratosis focal palmoplantar gingival
Summary
Focal palmoplantar and gingival keratoderma (MONDO:0007860) is a disease. A subtype of focal palmoplantar keratoderma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 9
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 17 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
9 HPO clinical features (Orphanet curated; top 9 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000212 | Gingival overgrowth | Very frequent (80-99%) |
| HP:0000222 | Gingival hyperkeratosis | Very frequent (80-99%) |
| HP:0000982 | Palmoplantar keratoderma | Very frequent (80-99%) |
| HP:0001231 | Abnormal fingernail morphology | Very frequent (80-99%) |
| HP:0007497 | Focal friction-related palmoplantar hyperkeratosis | Very frequent (80-99%) |
| HP:0008392 | Subungual hyperkeratosis | Very frequent (80-99%) |
| HP:0008399 | Circumungual hyperkeratosis | Very frequent (80-99%) |
| HP:0000975 | Hyperhidrosis | Frequent (30-79%) |
| HP:0001597 | Abnormality of the nail | Frequent (30-79%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | focal palmoplantar and gingival keratoderma |
| Mondo ID | MONDO:0007860 |
| MeSH | C536157 |
| OMIM | 148730 |
| Orphanet | 2200 |
| DOID | DOID:0070553 |
| SNOMED CT | 764963007 |
| UMLS | C1835650 |
| MedGen | 372097 |
| GARD | 0003098 |
| Is cancer (heuristic) | no |
Also known as: focal palmoplantar and gingival hyperkeratosis · focal palmoplantar and oral mucosa hyperkeratosis · keratosis focal palmoplantar gingival
Disease family
This is a subtype of focal palmoplantar keratoderma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › integumentary system disorder › skin disorder › keratosis › palmoplantar keratosis › hereditary palmoplantar keratoderma › focal palmoplantar keratoderma › focal palmoplantar and gingival keratoderma
Related subtypes (11): hereditary painful callosities, palmoplantar keratoderma-esophageal carcinoma syndrome, tyrosinemia type II, hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome, palmoplantar keratoderma, nonepidermolytic, focal 1, nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome, wooly hair-palmoplantar keratoderma syndrome, isolated focal non-epidermolytic palmoplantar keratoderma, pachyonychia congenita, focal palmoplantar keratoderma with joint keratoses, striate palmoplantar keratoderma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.